Indian pharmaceutical giant Wockhardt is putting itself up for grabs. The company, known for its extensive portfolio of generic and branded pharmaceuticals, has been facing challenges in recent quarters. Sources close to the negotiations suggest that Wockhardt is {attracting interest from|being courted by both domestic and international firms. A fi